Patent AT-E400649-T1: [Translated] NEW METHOD FOR INDUCING CELLULAR SENSENCE AND SCREENING METHOD FOR AN ANTI-AGING AGENT
Transformed cells obtained by transferring into normal cells with a gene encoding a protein capable of phosphorylation of p38 protein, or the p38 protein, a variant of the p38 protein, the kinase domain of the p38 protein, the kinase domain of p38 protein variant or a fused protein containing any of them, are new. Independent claims are also included for: (1) screening compounds using normal cells transferred with a gene to induce normal aging cells or cell aging comprising: (a) contacting with a test substance; and (b) analysis of an aging indication in cells; (2) anti-aging agents thus screened; and (3) anti-aging drug compositions containing the screened compounds which are inhibitors of the p38 protein, or a molecule located downstream of p38 in the p38 MAPK pathway or its fused protein. ACTIVITY : Anti-aging. No biological data is given. MECHANISM OF ACTION : None given.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[ "009:25" ] |
| contactPoint |
{ "fn": "NIH/NCBI Data Team", "@type": "vcard:Contact", "hasEmail": "mailto:info@ncbi.nlm.nih.gov" } |
| description | Transformed cells obtained by transferring into normal cells with a gene encoding a protein capable of phosphorylation of p38 protein, or the p38 protein, a variant of the p38 protein, the kinase domain of the p38 protein, the kinase domain of p38 protein variant or a fused protein containing any of them, are new. Independent claims are also included for: (1) screening compounds using normal cells transferred with a gene to induce normal aging cells or cell aging comprising: (a) contacting with a test substance; and (b) analysis of an aging indication in cells; (2) anti-aging agents thus screened; and (3) anti-aging drug compositions containing the screened compounds which are inhibitors of the p38 protein, or a molecule located downstream of p38 in the p38 MAPK pathway or its fused protein. ACTIVITY : Anti-aging. No biological data is given. MECHANISM OF ACTION : None given. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Official Data Source", "mediaType": "text/html", "description": "Access the complete Patent AT-E400649-T1: [Translated] NEW METHOD FOR INDUCING CELLULAR SENSENCE AND SCREENING METHOD FOR AN ANTI-AGING AGENT on the official website.", "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400649-T1" } ] |
| identifier | https://healthdata.gov/api/views/vsm2-azwv |
| issued | 2025-09-05 |
| keyword |
[ "chemistry", "innovation", "patent", "pubchem", "research" ] |
| landingPage | https://healthdata.gov/d/vsm2-azwv |
| modified | 2025-09-06 |
| programCode |
[ "009:066" ] |
| publisher |
{ "name": "National Center for Biotechnology Information (NCBI)", "@type": "org:Organization" } |
| theme |
[ "NIH" ] |
| title | Patent AT-E400649-T1: [Translated] NEW METHOD FOR INDUCING CELLULAR SENSENCE AND SCREENING METHOD FOR AN ANTI-AGING AGENT |
